ETR:EVT - Evotec A.G. Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
€14.59 +0.31 (+2.17 %)
(As of 05/24/2018 04:00 PM ET)
Previous Close€14.59
Today's Range€14.27 - €14.59
52-Week Range€7.91 - €22.50
Volume1.24 million shs
Average Volume1.36 million shs
Market Capitalization$2.36 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Evotec A.G. (ETR:EVT)

Evotec A.G. logoEvotec AG provides drug discovery and development solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and not-for-profit organizations worldwide. The company operates through two segments, EVT Execute and EVT Innovate. It offers drug discovery services, such as integrated services, target identification and validation, hit identification, compound management, chemistry, drug metabolism and pharmacokinetics, research informatics and in silico drug discovery, proteomics and metabolomics, cell and protein production, and in vivo and in vitro pharmacology services, as well as absorption, distribution, metabolism, excretion, and toxicity services. The company is also involved in investing and developing proprietary assets, including early-stage discovery programmes, as well as advanced drug candidates in the areas of diabetes and diabetic complications, inflammatory diseases, neuroscience, oncology, and pain and anti-infective. Evotec AG was founded in 1993 and is headquartered in Hamburg, Germany.

Receive EVT News and Ratings via Email

Sign-up to receive the latest news and ratings for EVT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolETR:EVT
CUSIPN/A
Phone+49-40-560810

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins4.35%
Return on Equity3.74%
Return on Assets2.21%

Miscellaneous

EmployeesN/A
Outstanding Shares147,270,000

Evotec A.G. (ETR:EVT) Frequently Asked Questions

What is Evotec A.G.'s stock symbol?

Evotec A.G. trades on the ETR under the ticker symbol "EVT."

What price target have analysts set for EVT?

4 brokers have issued twelve-month price objectives for Evotec A.G.'s shares. Their predictions range from €14.00 to €20.00. On average, they expect Evotec A.G.'s share price to reach €17.50 in the next year. View Analyst Ratings for Evotec A.G..

Who are Evotec A.G.'s key executives?

Evotec A.G.'s management team includes the folowing people:
  • Dr. Werner Lanthaler, CEO & Member of Management Board (Age 50)
  • Mr. Enno Spillner, CFO & Member of Management Board (Age 48)
  • Dr. Mario Polywka, COO & Member of Management Board (Age 55)
  • Dr. Cord Dohrmann, Chief Scientific Officer & Member of Management Board (Age 54)
  • Ms. Anja Bosler, Principal Accounting Officer and Sr. VP of Group Accounting

Has Evotec A.G. been receiving favorable news coverage?

Media stories about EVT stock have trended somewhat positive this week, according to Accern Sentiment Analysis. Accern identifies positive and negative press coverage by monitoring more than 20 million blog and news sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Evotec A.G. earned a news sentiment score of 0.17 on Accern's scale. They also gave news headlines about the company an impact score of 46.43 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the next few days.

What is Evotec A.G.'s stock price today?

One share of EVT stock can currently be purchased for approximately €14.59.

How big of a company is Evotec A.G.?

Evotec A.G. has a market capitalization of $2.36 billion.

How can I contact Evotec A.G.?

Evotec A.G.'s mailing address is Essener Bogen 7, HAMBURG, 22419, Germany. The company can be reached via phone at +49-40-560810.


MarketBeat Community Rating for Evotec A.G. (EVT)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  70 (Vote Outperform)
Underperform Votes:  76 (Vote Underperform)
Total Votes:  146
MarketBeat's community ratings are surveys of what our community members think about Evotec A.G. and other stocks. Vote "Outperform" if you believe EVT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EVT will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Evotec A.G. (ETR:EVT) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
4 Wall Street analysts have issued ratings and price targets for Evotec A.G. in the last 12 months. Their average twelve-month price target is €17.50The high price target for EVT is €20.00 and the low price target for EVT is €14.00. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyHold
Consensus Rating Score: 2.502.502.502.25
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: €17.50€17.50€16.75€16.75

Evotec A.G. (ETR:EVT) Consensus Price Target History

Price Target History for Evotec A.G. (ETR:EVT)

Evotec A.G. (ETR:EVT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
4/3/2018Deutsche BankSet Price TargetBuy€20.00View Rating Details
3/28/2018Berenberg BankSet Price TargetNeutral€16.00View Rating Details
3/7/2018Oddo BhfSet Price TargetBuy€20.00View Rating Details
8/11/2017Oddo SecuritiesSet Price TargetNeutral€14.00View Rating Details
(Data available from 5/24/2016 forward)

Earnings

Dividends

Evotec A.G. (ETR:EVT) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Evotec A.G. (ETR EVT) Insider Trading and Institutional Ownership History

Insider Trading History for Evotec A.G. (ETR:EVT)

Evotec A.G. (ETR EVT) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Evotec A.G. (ETR EVT) News Headlines

Source:
DateHeadline
Celgene Forges Oncology Partnership With Germanys EvotecCelgene Forges Oncology Partnership With Germany's Evotec
finance.yahoo.com - May 22 at 3:49 PM
Does Evotec AG’s (ETR:EVT) -11.89% Earnings Drop Reflect A Longer Term Trend?Does Evotec AG’s (ETR:EVT) -11.89% Earnings Drop Reflect A Longer Term Trend?
finance.yahoo.com - May 10 at 3:51 PM
Evotec Reports First Quarter 2018 Results and Provides Corporate UpdateEvotec Reports First Quarter 2018 Results and Provides Corporate Update
finance.yahoo.com - May 9 at 10:17 AM
Evotec to Present at Upcoming Investor ConferencesEvotec to Present at Upcoming Investor Conferences
finance.yahoo.com - May 4 at 10:06 AM
Evotec AG (ETR:EVT): What Can We Expect From This High Growth Stock?Evotec AG (ETR:EVT): What Can We Expect From This High Growth Stock?
finance.yahoo.com - May 2 at 3:51 PM
Evotec AG to Report First Quarter 2018 Results on 09 May 2018Evotec AG to Report First Quarter 2018 Results on 09 May 2018
finance.yahoo.com - May 2 at 10:08 AM
Deutsche Bank Reiterates €16.00 Price Target for Evotec A.G. (EVT)Deutsche Bank Reiterates €16.00 Price Target for Evotec A.G. (EVT)
www.americanbankingnews.com - April 13 at 11:23 AM
Berenberg Bank Analysts Give Evotec A.G. (EVT) a €13.00 Price TargetBerenberg Bank Analysts Give Evotec A.G. (EVT) a €13.00 Price Target
www.americanbankingnews.com - April 11 at 2:55 PM
Evotec A.G. (EVT) Given a €16.00 Price Target at Deutsche BankEvotec A.G. (EVT) Given a €16.00 Price Target at Deutsche Bank
www.americanbankingnews.com - April 10 at 6:40 PM
Deutsche Bank Reiterates €20.00 Price Target for Evotec (EVT)Deutsche Bank Reiterates €20.00 Price Target for Evotec (EVT)
www.americanbankingnews.com - April 3 at 9:22 AM
Evotec (EVT) PT Set at €17.00 by Deutsche BankEvotec (EVT) PT Set at €17.00 by Deutsche Bank
www.americanbankingnews.com - April 1 at 9:14 PM
Evotec (EVT) Given a €16.00 Price Target by Berenberg Bank AnalystsEvotec (EVT) Given a €16.00 Price Target by Berenberg Bank Analysts
www.americanbankingnews.com - April 1 at 10:52 AM
What Does Evotec AG’s (ETR:EVT) Share Price Indicate?What Does Evotec AG’s (ETR:EVT) Share Price Indicate?
finance.yahoo.com - March 28 at 10:32 AM
Evotec (EVT) Given a €16.00 Price Target at Berenberg BankEvotec (EVT) Given a €16.00 Price Target at Berenberg Bank
www.americanbankingnews.com - March 28 at 9:32 AM
Evotec AG plans conversion into European Company (SE)Evotec AG plans conversion into European Company (SE)
finance.yahoo.com - March 27 at 3:47 PM
Evotec AG to Report Fiscal Year 2017 Results on 28 March 2018Evotec AG to Report Fiscal Year 2017 Results on 28 March 2018
finance.yahoo.com - March 21 at 11:34 AM
What You Must Know About Evotec AG’s (ETR:EVT) Return on EquityWhat You Must Know About Evotec AG’s (ETR:EVT) Return on Equity
finance.yahoo.com - March 19 at 3:42 PM
Evotec (EVT) Given a €20.00 Price Target at Oddo BhfEvotec (EVT) Given a €20.00 Price Target at Oddo Bhf
www.americanbankingnews.com - March 7 at 9:36 AM
Evotec and MaRS Innovation Announce First Funded Project under LAB150 BridgeEvotec and MaRS Innovation Announce First Funded Project under LAB150 Bridge
finance.yahoo.com - February 23 at 10:19 AM
EVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGEEVOTEC AG AND MARS INNOVATION ANNOUNCE FIRST FUNDED PROJECT UNDER LAB150 BRIDGE
www.streetinsider.com - February 15 at 9:21 AM
Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi - Business Wire (press release)Evotec and Apeiron Achieve First Milestone in Immuno-Oncology Alliance with Sanofi - Business Wire (press release)
www.businesswire.com - January 8 at 11:17 AM
Evotecs Academic Bridge LAB282 with Oxford University Celebrating One Year of ImpactEvotec's Academic Bridge LAB282 with Oxford University Celebrating One Year of Impact
finance.yahoo.com - December 11 at 9:42 AM
Deutsche Bank Reiterates €17.00 Price Target for Evotec (EVT)Deutsche Bank Reiterates €17.00 Price Target for Evotec (EVT)
www.americanbankingnews.com - December 10 at 8:42 PM
Evotec (EVT) PT Set at €16.00 by Berenberg BankEvotec (EVT) PT Set at €16.00 by Berenberg Bank
www.americanbankingnews.com - December 7 at 9:56 PM
Evotec AG (EVT) Given a €20.00 Price Target at Oddo BhfEvotec AG (EVT) Given a €20.00 Price Target at Oddo Bhf
www.americanbankingnews.com - November 9 at 6:24 AM
Evotec AG Announces First Nine-Month 2017 Results and Corporate Update - Business Wire (press release)Evotec AG Announces First Nine-Month 2017 Results and Corporate Update - Business Wire (press release)
www.businesswire.com - November 9 at 2:51 AM
Evotec AG Announces First Nine-Month 2017 Results and Corporate UpdateEvotec AG Announces First Nine-Month 2017 Results and Corporate Update
finance.yahoo.com - November 8 at 6:41 AM
Evotec Joins Forces with Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build NEPLEXEvotec Joins Forces with Academic Leaders to Accelerate Drug Discovery in Kidney Diseases and Build 'NEPLEX'
finance.yahoo.com - November 6 at 4:09 AM
Evotec AG to Report First Nine-Month 2017 Results on 08 November 2017 - Business Wire (press release)Evotec AG to Report First Nine-Month 2017 Results on 08 November 2017 - Business Wire (press release)
www.businesswire.com - November 3 at 11:34 PM
Evotec AG to Report First Nine-Month 2017 Results on 08 November 2017Evotec AG to Report First Nine-Month 2017 Results on 08 November 2017
finance.yahoo.com - November 2 at 7:41 PM
Evotec and TESARO Enter Strategic Partnership to Discover Novel Immuno-Oncology Agents - Business Wire (press release)Evotec and TESARO Enter Strategic Partnership to Discover Novel Immuno-Oncology Agents - Business Wire (press release)
www.businesswire.com - October 26 at 11:02 PM
Evotec and TESARO Enter Strategic Partnership to Discover Novel Immuno-Oncology AgentsEvotec and TESARO Enter Strategic Partnership to Discover Novel Immuno-Oncology Agents
finance.yahoo.com - October 26 at 12:47 PM
Evotec Achieves First Milestone in Neurodegeneration Alliance with CelgeneEvotec Achieves First Milestone in Neurodegeneration Alliance with Celgene
finance.yahoo.com - October 10 at 4:49 AM
Evotec Invests in Exscientia to Advance AI-Driven Drug Discovery - Business Wire (press release)Evotec Invests in Exscientia to Advance AI-Driven Drug Discovery - Business Wire (press release)
www.businesswire.com - September 28 at 6:15 PM
Berenberg Bank Reiterates "€16.00" Price Target for Evotec AG (EVT)Berenberg Bank Reiterates "€16.00" Price Target for Evotec AG (EVT)
www.americanbankingnews.com - September 19 at 6:30 AM
MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO - GlobeNewswire (press release)MARS INNOVATION AND EVOTEC AG ESTABLISH ACADEMIC BRIDGE “LAB150” IN TORONTO - GlobeNewswire (press release)
globenewswire.com - September 14 at 7:09 PM
Evotec and MaRS Innovation Establish Academic Bridge LAB150 in TorontoEvotec and MaRS Innovation Establish Academic Bridge 'LAB150' in Toronto
finance.yahoo.com - September 14 at 5:53 AM
European Investment Bank Supports Evotecs Innovate Strategy with EUR 75 M LoanEuropean Investment Bank Supports Evotec's Innovate Strategy with EUR 75 M Loan
finance.yahoo.com - September 8 at 6:55 PM
Evotec and ABIVAX Enter into Strategic Collaboration to Develop Novel Antiviral AgentsEvotec and ABIVAX Enter into Strategic Collaboration to Develop Novel Antiviral Agents
finance.yahoo.com - September 7 at 6:13 AM
Evotec to Attend Upcoming Investor ConferencesEvotec to Attend Upcoming Investor Conferences
finance.yahoo.com - September 6 at 6:25 PM
Evotec AG (EVT) Given a €16.00 Price Target by Deutsche Bank AG AnalystsEvotec AG (EVT) Given a €16.00 Price Target by Deutsche Bank AG Analysts
www.americanbankingnews.com - August 30 at 3:06 PM
Evotec AG (EVT) Given a €16.00 Price Target by Berenberg Bank AnalystsEvotec AG (EVT) Given a €16.00 Price Target by Berenberg Bank Analysts
www.americanbankingnews.com - August 20 at 6:22 PM
Evotec Completes Acquisition of AptuitEvotec Completes Acquisition of Aptuit
finance.yahoo.com - August 16 at 5:16 AM
Evotec AG (ETR:EVT) Given a €14.00 Price Target by Oddo Securities AnalystsEvotec AG (ETR:EVT) Given a €14.00 Price Target by Oddo Securities Analysts
www.americanbankingnews.com - August 13 at 5:50 PM
Evotecs (EVOTF) CEO Werner Lanthaler on Q2 2017 Results - Earnings Call TranscriptEvotec's (EVOTF) CEO Werner Lanthaler on Q2 2017 Results - Earnings Call Transcript
seekingalpha.com - August 11 at 12:49 AM
Evotec Announces First Half Year 2017 Results and Corporate UpdateEvotec Announces First Half Year 2017 Results and Corporate Update
finance.yahoo.com - August 10 at 4:40 AM
Evotec AG to Report First Half-Year 2017 Results on 10 August 2017 - Business Wire (press release)Evotec AG to Report First Half-Year 2017 Results on 10 August 2017 - Business Wire (press release)
www.businesswire.com - August 4 at 6:42 PM
Evotec and Fraunhofer IME-SP Sign Strategic Collaboration on IPSC TechnologyEvotec and Fraunhofer IME-SP Sign Strategic Collaboration on IPSC Technology
finance.yahoo.com - August 3 at 5:28 AM
Evotec AG to Report First Half-Year 2017 Results on 10 August 2017Evotec AG to Report First Half-Year 2017 Results on 10 August 2017
finance.yahoo.com - August 3 at 5:27 AM
Evotec AG (ETR:EVT) Given a €13.00 Price Target at Berenberg BankEvotec AG (ETR:EVT) Given a €13.00 Price Target at Berenberg Bank
www.americanbankingnews.com - July 31 at 9:08 AM

SEC Filings

Evotec A.G. (ETR:EVT) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Social activity is not available for this stock.

Financials

Financials are not available for this stock.

Chart

Evotec A.G. (ETR EVT) Stock Chart for Thursday, May, 24, 2018

Loading chart…

This page was last updated on 5/24/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.